Abstract
Several lines of evidence have suggested altered functions of the brain-derived neurotrophic factor (BDNF) in the pathogenesis of neurodegenerative diseases including Alzheimer's disease (AD). In the search for polymorphisms in the 5′-flanking and 5′-noncoding regions of the BDNF gene, we found a novel nucleotide substitution (C270T) in the noncoding region. We performed an association study between this polymorphism and AD in a Japanese sample of 170 patients with sporadic AD (51 early-onset and 119 late-onset) and 498 controls. The frequency of individuals who carried the mutated type (T270) was significantly more common in patients with late-onset AD than in controls (P = 0.00004, odds ratio: 3.8, 95% CI 1.9–7.4). However, there was no significant difference in the genotype distribution between the patients with early-onset AD and the controls, although this might be due to the small sample size of the early-onset group. Our results suggest that the C270T polymorphism of the BDNF gene or other unknown polymorphisms, which are in linkage disequilibrium, give susceptibility to late-onset AD. We obtained no evidence for the possible interactions between the BDNF and apolipoprotein E (APOE) genes, suggesting that the possible effect of the BDNF gene on the development of late-onset AD might be independent of the APOE genotype.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Terry RD . Neuropathological changes in Alzheimer disease Prog Brain Res 1994 101: 383–390
Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M et al. Cloning of a gene bearing mis-sense mutations in early-onset familial Alzheimer's disease Nature 1995 375: 754–760
Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus Science 1995 269: 973–977
Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease Nature 1991 349: 704–706
Saunders AM, Strittmatter WJ, Schmechel D, St . George-Hyslop PH, Pericak-Vance MA, Joo SH et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease Neurology 1993 43: 1467–1472
Maisonpierre PC, Belluscio L, Friedman B, Alderson RF, Wiegand SJ, Furth ME et al. NT3, BDNF and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression Neuron 1990 5: 501–509
Maisonpierre PC, Le Beau MM, Espinosa III R, Ip NY, Belluscio L, de la Monte SM et al. Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations Genomics 1991 10: 558–568
Connor B, Young D, Yan Q, Faull RL, Synek B, Dragunow M . Brain-derived neurotrophic factor is reduced in Alzheimer's disease Brain Res Mol Brain Res 1997 49: 71–81
Ferrer I, Marin C, Rey MJ, Ribalta T, Goutan E, Blanco R et al. BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies J Neuropathol Exp Neurol 1999 58: 729–739
Narisawa-Saito M, Wakabayashi K, Tsuji S, Takahashi H, Nawa H . Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease Neuroreport 1996 7: 2925–2928
Knusel B, Gao H . Neurotrophins and Alzheimer's disease: beyond the cholinergic neurons Life Sci 1996 58: 2019–2027
Lindsay RM . Neurotrophic growth factors and neurodegenerative diseases: therapeutic potential of the neurotrophins and ciliary neurotrophic factor Neurobiol Aging 1994 15: 249–251
Shintani A, Ono Y, Kaisho Y, Igarashi K . Characterization of the 5′-flanking region of the human brain-derived neurotrophic factor gene Biochem Biophys Res Commun 1992 182: 325–332
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM . Clinical diagnosis of Alzheimer's disease Neurology 1984 34: 939–944
Wenham PR, Price WH, Blundell GB . Apolipoprotein E genotyping by one-stage PCR Lancet 1991 337: 1158–1159
Acknowledgements
This work was supported by the Pharmacopsychiatry Research Foundation. We thank Ms N Okuyama for her assistance in the laboratory.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kunugi, H., Ueki, A., Otsuka, M. et al. A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease. Mol Psychiatry 6, 83–86 (2001). https://doi.org/10.1038/sj.mp.4000792
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4000792
Keywords
This article is cited by
-
Necrostatin-1 Relieves Learning and Memory Deficits in a Zebrafish Model of Alzheimer’s Disease Induced by Aluminum
Neurotoxicity Research (2022)
-
Intranasal delivery of BDNF rescues memory deficits in AD11 mice and reduces brain microgliosis
Aging Clinical and Experimental Research (2021)
-
Neurotrophin Signaling and Stem Cells—Implications for Neurodegenerative Diseases and Stem Cell Therapy
Molecular Neurobiology (2017)
-
Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer’s disease
Translational Psychiatry (2016)
-
Brain-Derived Neurotrophic Factor in Alzheimer’s Disease: Risk, Mechanisms, and Therapy
Molecular Neurobiology (2015)